Safety Assessment of a Multipeptide-gene Vaccine in CML

Clinical trial NCT00455221 · COMPLETED

Trial details

NCT number: NCT00455221
Sponsor: Tehran University of Medical Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Chronic

Start date: 2008-02-01
Primary completion: 2010-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.